Onderzoeker
Christel Fontaine
- Trefwoorden:Geneeskunde
- Disciplines:Kankertherapie
Affiliaties
- Medische Oncologie (Departement)
Lid
Vanaf1 jun 2010 → Heden - Laboratorium Moleculaire Oncologie (Onderzoeksgroep)
Lid
Vanaf1 jan 2010 → Heden - Observerende Klinische wetenschappen (Departement)
Lid
Vanaf5 jan 2021 → Heden - Observerende Klinische wetenschappen (Departement)
Lid
Vanaf1 mei 2012 → Heden
Publicaties
1 - 10 van 46
- Towards precision pain medicine for pain after cancer: the Cancer Pain Phenotyping Network multidisciplinary international guidelines for pain phenotyping using nociplastic pain criteria(2023)
Auteurs: Jo Nijs, Astrid Lahousse, César Fernández-de-Las-Peñas, Pascal Madeleine, Christel Fontaine, Tomohiko Nishigami, Christine Desmedt, Marian Vanhoeij, Kenza Mostaqim, Antonio I Cuesta-Vargas, et al.
Pagina's: 611-621 - Lung Restriction in Patients With Breast Cancer After Hypofractionated and Conventional Radiation Therapy(2022)
Auteurs: Sylvia Verbanck, Hilde Van Parijs, Daniël Schuermans, Vincent Vinh-Hung, Guy Storme, Christel Fontaine, Mark De Ridder, Dirk Verellen, Eef Vanderhelst, S Hanon
Pagina's: 561-569 - ROSALINE(2022)
Auteurs: Elisa Agostinetto, Guilherme Nader-Marta, Marianne Paesmans, Lieveke Ameye, Isabelle Veys, Laurence Buisseret, Patrick Neven, Donatienne Taylor, Christel Fontaine, Francois P Duhoux, et al.
Pagina's: 2381-2392 - Sacituzumab govitecan as second-line treatment for metastatic triple-negative breast cancer-phase 3 ASCENT study subanalysis(2022)
Auteurs: Lisa A. Carey, Delphine Loirat, Kevin Punie, Aditya Bardia, Véronique Diéras, Florence Dalenc, Jennifer Robinson Diamond, Christel Fontaine, Grace Wang, Hope S. Rugo, et al.
Pagina's: 1-72 - Efficacy of a Flat Low Dose of Nivolumab in Advanced Cancer(2022)
Auteurs: Sofie Joris, Christel Fontaine, Lore Decoster, Jacques Vanderauwera, Kris Thielemans, Wim Waelput, Jacques De Greve
Pagina's: 1433-1437 - Gini's mean difference and the long-term prognostic value of nodal quanta classes after pre-operative chemotherapy in advanced breast cancer(2022)
Auteurs: Vincent Vinh-Hung, Hilde Van Parijs, Olena Gorobets, Christel Fontaine, Nam P Nguyen, Bhumsuk Keam, Dung Minh Nguyen, Mark De Ridder
- Cardiopulmonary-related patient-reported outcomes in a randomized clinical trial of radiation therapy for breast cancer.(2021)
Auteurs: Hilde Van Parijs, Vincent Vinh-Hung, Christel Fontaine, Guy Storme, Claire Verschraegen, Dung M. Nguyen, Nele Adriaenssens, Nam P Nguyen, Olena Gorobets, Mark De Ridder
- Supportive care for cancer patients(2021)
Auteurs: Christel Fontaine, Marie-Aline Echterbille, Jean Klastersky
Pagina's: 5507-5512 - A randomised wait-list controlled trial to evaluate Emotional Freedom Techniques for self-reported cancer-related cognitive impairment in cancer survivors (EMOTICON)(2021)
Auteurs: Laura Tack, Tessa Lefebvre, Michelle Lycke, Christine Langenaeken, Christel Fontaine, Marleen Borms, Marianne Hanssens, Christel Knops, Kathleen Meryck, Tom Boterberg, et al.
- Phase I trial of 131I-GMIB-Anti-HER2-VHH1, a new promising candidate for HER2-targeted radionuclide therapy in breast cancer patients(2021)
Auteurs: Matthias D'Huyvetter, Jens De Vos, Vicky Caveliers, Ilse Vaneycken, Johannes Heemskerk, Francois P Duhoux, Christel Fontaine, Marian Vanhoeij, Albert D Windhorst, Frank Van Der Aa, et al.
Pagina's: 1097-1105